Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS), and experimental autoimmune encephalomyelitis (EAE) is a well‐established animal model of the disease. Here, we examined the pathophysiological role of Kallikrein 6 (Klk6), a serine protease produced by oligodendrocytes (OLs), in EAE using Klk6 knockout (Klk6−/−) mice. Compared with Klk6+/+ (wild‐type) mice, Klk6−/− mice showed milder EAE symptoms, including delayed onset and milder paralysis. Loss of Klk6 suppressed matrix metalloprotease‐9 expression and diminished the infiltration of peripheral inflammatory cells into the CNS by decreasing blood–brain barrier (BBB) permeability and reducing expression levels of inflammatory cytokines, chemokines and their receptors. Scanning electron microscopic analysis revealed demyelination characterized by myelin detachment from the axons in the early phase of EAE progression (days 3–7) in Klk6+/+ mice but not in Klk6−/− mice. Interestingly, anti‐MOG (myelin oligodendrocyte glycoprotein) autoantibody was also detected in the cerebrospinal fluid (CSF) and spinal cord on day 3 after MOG immunization. Furthermore, treatment of primary cultured OLs with anti‐MOG autoantibody induced oligodendroglial morphological changes and increases in myelin basic protein and Klk6 expression. We also developed a novel enzyme‐linked immunoabsorbent assay method for detecting activated KLK6 in human CSF. In human autopsy brain samples, expression of active KLK6 was detected in OLs using an antibody that specifically recognizes the protein's activated form. Taken together, our findings demonstrate that Klk6 secreted by OLs plays a critical role in the pathogenesis of EAE/MS and that it might serve as a potential therapeutic target for MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004 · cited 3×
“, 2013) and knockout of MMP-9 reduces BBB leakage (Asahi et al., 2001).”
BackgroundResultMultiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · cited 1×
“…cross the blood–brain barrier (BBB), and aggressively target putative myelin antigens in the central nervous system (CNS), causing inflammation, demyelination, axonal injury, astrogliosis, and ultimately, neurodegeneration (Dhib-Jalbut, 2007; Hafler et al., 2005; McFarland & Martin, 2007).”
BackgroundRosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
Rosenberg, G. A., Cunningham, L. A., Wallace, J., Alexander, S., Estrada, E. Y., Grossetete, M., Razhagi, A., Miller, K., & Gearing, A. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03294-7 · Cited by 388 · cited 2×
“Microglia are also an important source of MMP-9 (del Zoppo et al., 2007), and expression of MMP-9 is observed in microglia at inflammatory sites (Rosenberg et al., 2001; Song et al., 2015).”
BackgroundArima, Y., Harada, M., Kamimura, D., Park, J.-H., Kawano, F., Yull, F. E., Kawamoto, T., Iwakura, Y., Betz, U. A. K., Márquez, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.022 · Cited by 307 · cited 4×
“…CCL2/MCP-1 S: 50- CCGGCTGGAGCATCCACGTGT-30 Arima et al. (2012) CCL2/MCP-1 AS: 50- TGGGGTCAGCACAGACCTCTCTCT-30 CCL20 S: 50-ACAGTGTGGGAAGCAAGTCC-30 Arima et al. (2012) CCL20 AS: 50-CCGTGAACTCCTTTGACCAT-30 CCR2 S: 50-ATG TTA CCT CAG TTC ATC CAC GGC-30 Arima et al. (2012) CCR2 AS: 50-GTA ATG GTG…”
BackgroundInfluentialIglesias, A., Bauer, J., Litzenburger, T., Schubart, A., & Linington, C. (2001) · Glia · doi:10.1002/glia.1111 · Cited by 280
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Spadaro, M., Gerdes, L. A., Krumbholz, M., Ertl-Wagner, B., Thaler, F. S., Schuh, E., Metz, I., Blaschek, A., Dick, A., Brück, W., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000257 · Cited by 206
Engström, L., Rosén, K., Angel, A., Fyrberg, A., Mackerlova, L., Konsman, J. P., Engblom, D., & Blomqvist, A. (2008) · Endocrinology · doi:10.1210/en.2007-1456 · Cited by 69
Cited by
Molecular Architecture of the Mouse Nervous System
Zeisel, A., Hochgerner, H., Lönnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., Häring, M., Braun, E., Borm, L. E., La Manno, G., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.021 · Cited by 2,552
A shared disease-associated oligodendrocyte signature among multiple CNS pathologies
Kenigsbuch, M., Bost, P., Halevi, S., Chang, Y., Chen, S., Ma, Q., Hajbi, R., Schwikowski, B., Bodenmiller, B., Fu, H., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01104-7 · Cited by 233
Floriddia, E. M., Lourenço, T., Zhang, S., van Bruggen, D., Hilscher, M. M., Kukanja, P., Gonçalves dos Santos, J. P., Altınkök, M., Yokota, C., Llorens-Bobadilla, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19453-x · Cited by 159
Geisler, J. G. (2019) · Cells · doi:10.3390/cells8030280 · Cited by 104
Metadata
- Authors
- Bando, Y., Hagiwara, Y., Suzuki, Y., Yoshida, K., Aburakawa, Y., Kimura, T., Murakami, C., Ono, M., Tanaka, T., Jiang, Y., Mitrovi, B., Bochimoto, H., Yahara, O., & Yoshida, S.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2017-10-31
- Volume
- 66
- Issue
- 2
- Pages
- 359-378
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2767141291
- Cited by
- 49
- References
- 9
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. https://app.cochat.ai/papers/10.1002/glia.23249
- The paper
- Bando, Y., Hagiwara, Y., Suzuki, Y., Yoshida, K., Aburakawa, Y., Kimura, T., Murakami, C., Ono, M., Tanaka, T., Jiang, Y., Mitrovi, B., Bochimoto, H., Yahara, O., & Yoshida, S. (2018). Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. Glia. https://doi.org/10.1002/glia.23249
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.